Researchers have discovered hepatitis C virus (HCV) in the brain lining of individuals with schizophrenia and bipolar ...

Observational studies of psychiatric diseases such as schizophrenia, bipolar disorder and major depression have long tied ...

A new medical study out of Johns Hopkins Children's Center could potentially be a game changer for those suffering certain ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be answered about scalability and costs, experts say.

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

Titusville: Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have ...

The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, ...

The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...

Johnson & Johnson (NYSE: JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced ...

Latest research at the Epilepsy Society using pioneering research equipment has shown parallels between people with ...

Receiving a schizophrenia diagnosis can be devastating. Many are unaware they are sick, refusing medication, temporarily unable to work, and disjointed from friends.